$1.86
10.14% today
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US98386D3070
Symbol
XTLB
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Health
Industry
Biotechnology

XTL Biopharmaceuticals Ltd. Sponsored ADR Stock News

Neutral
GlobeNewsWire
●
5 months ago
XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million
expands its IP portfolio to AI Web Data The Social Proxy is a web data AI company  developing and powering an IP based platform for AI & BI Applications at scale Completed a Private Placement of $1.5 Million   RAMAT GAN, ISRAEL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- August 14, 2024, XTL Biopharmaceuticals Ltd. (the “Company” or “XTL”) announced today it has completed the acquisition of THE SOCIAL P...

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today